Effect of 12 Weeks of Treatment with PF-06650833 on Rheumatoid Arthritis
A 12 Week Randomized, Double-Blind, Double Dummy, Parallel Group, Active and Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety Profile of PF-06650833 in Subjects With Active Rheumatoid Arthritis With an Inadequate Response to Methotrexate
Category & Conditions: Immune System Diseases and Conditions
Medicine: PF-06650833
ClinicalTrials.gov Identifier (NCT): NCT02996500
Protocol ID: B7921005
PrintDownloadOpen Plain Language Summary Result: Click here